Related Experiment Video
Updated: Oct 20, 2026

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
Published on: January 22, 2015
Astaxanthin-zein-polysaccharide nanoparticles via intelligent microfluidics: Ionic-type polysaccharides
Mengju Xu1, Ruitao Zhao1, Yumeng Miao1
1College of Biotechnology, Tianjin University of Science & Technology, Tianjin, 300457, China.
Abstract:
Astaxanthin (AST), a potent lipophilic antioxidant, suffers from poor water solubility, environmental instability and low bioavailability, severely restricting its application in functional foods. In this study, six AST-Zein-polysaccharide ternary nanoparticles were precisely fabricated via an advancedcomputer-integrated intelligently controlled microfluidic platform. Different from conventional thermal bulk methods, this non-thermal microfluidic technique achieves confined self-assembly and precise laminar mixing for efficient, reproducible fabrication of homogeneous nanoparticles. Six food-grade polysaccharides (gum arabic (GA), pectin, HPMC, chitosan, guar gum, and xanthan gum) were systematically compared, and AST-GA-NPs were screened as the optimal delivery system. These nanoparticles exhibited superior comprehensive performance with a small particle size (80.8 ± 2.6 nm), low PDI (0.116 ± 0.054), and excellent antioxidant activity (DPPH: 87.17 ± 1.13%; ABTS: 90.51 ± 1.76%), as well as good morphological regularity, hydrophilicity and stability under variable pH, salt and light conditions. Gastrointestinal simulation tests showed that the cumulative AST release rate of AST-GA-NPs reached 86.62 ± 0.39%, 7.94 times higher than that of free AST. Multispectral analysis verified that hydrogen bonding and hydrophobic interactions drove the stable self-assembly of nanoparticles. The unique highly branched structure and anionic characteristic of GA further optimized the interfacial characteristics and structural stability of the ternary system. This study proves the great superiority of computer-integrated microfluidics in constructing high-performance bioactive delivery systems, providing a feasible strategy for improving the stability and intestinal bioavailability of AST in functional foods.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Rate-Programmed I
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Modified-Release Drug Delivery Systems: Rate-Programmed II